Therapeutic Goods Act 1989
I, Larry Kelly, Coordinator, Monitoring & Compliance Group, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of section 42 DK (1) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of those goods or in information included in thepackage in which those goods are contained:
- representations to the effect that the goods described in paragraph (b) below may be used "For the treatment of patients with known cardiovascular or cerebrovascular disease as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke)" and "reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease, by helping to prevent blood clotting."
- PHARMACIST FORMULA CARDIO ASPIRIN 100mg enteric coated tablet blister pack
- supplied as an over-the-counter medicine by Medreich Australia Pty Ltd.
Dated this 10th day of November 2010.
Larry Kelly
Delegate of the Secretary to the Department of Health and Ageing